Curasan AG
-
Biologics
curasan AG broadens orthobiologic portfolio with the launch of CERASORB® CPC (Calcium Phosphate Cement) bone void fillers.
Frankfurt, Germany, July 25, 2022 /OrthoSpineNews/ – curasan AG (Frankfurt, Germany), a pioneer and leading global provider of biomaterials for…
Read More » -
Biologics
Xlife Sciences and curasan form joint venture company to research biosurgical treatment therapies
Kleinostheim, Germany, 21 March 2022, OrthoSpineNews – Xlife Sciences AG (SIX: XLS) and curasan AG, a leading global provider of…
Read More » -
Biologics
curasan signs new cooperation with Implantcast for the DACH-region
Kleinostheim, 30 November 2017 – curasan AG (ISIN DE0005494538), a leading specialist for medical products in the field of orthobiologics, has…
Read More » -
Financial
DGAP-News: Curasan starts dynamically into the new year
Kleinostheim, 18 May 2017 – curasan AG (ISIN DE0005494538), a leading specialist for medical products in the field of orthobiologics,…
Read More » -
Biologics
curasan receives approval for orthopedic product in the strategically important US market
Kleinostheim, 7 December 2016 – curasan AG, a leading specialist for medical products in the field of orthobiologics, has received…
Read More »